VivoTex offers 3D printed microfiber scaffolds designed to help researchers replicate tissue models more effectively than other scaffolds, matrices, or bioinks. Our proprietary melt electrowriting (MEW) technology—a cutting-edge 3D printing technique—creates highly precise, customizable scaffolds at the human cellular scale. This innovative process provides enhanced control over the cell micro-environment, accelerating cell growth, improving cell-to-cell communication, and boosting viability. Ideal for in vitro tissue engineering, cancer research, and drug discovery, customers may choose from a catalog of application-specific scaffolds or work with our engineering team to create a custom-designed solution that meets their study needs.
Company Details
- Employees
- 6
- Founded
- 2024
- Address
- Newberg, Oregon, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.vivotex.com
- Keywords
- Tissue Engineering, Cancer Research, Melt Electrowriting, Regenerative Medicine, Drug Discovery, Preclinical Research, Cellular Biology, Microfiber Scaffolds, Biofabrication, In-vitro Modeling, Biomedical Research, 3D Scaffolds, bioprinting, custom designed scaffolds, In-vitro tissue engineering, microenvironment, micro architecture, extracellular matrix, melt electrospinning, 3D Cell Culture, Tissue models.
- HQ
- Newberg, Oregon
Vivotex Questions
Vivotex's website is http://www.vivotex.com
Vivotex's LinkedIn profile is https://www.linkedin.com/company/vivotex-usa
Vivotex has
6 employees.
View email and phone details for 6
employees at Vivotex.
Vivotex's industry is
Biotechnology Research
Vivotex's top competitors are
Therafluor Inc,
Cascade Corporation,
Hothouse Theatre,
Corvallis Public Schools Foundation,
Vivotex,
Vivotex India Pvt. Ltd.,
4g Clinical,
A-Dec Inc.,
Holly Smith Strategic Search,
Vibe Oasis™.
Vivotex's categories are Biotechnology Research
Vivotex's founding year is 2024
